Scholars Central

Research articlePublished 3 May 2019

Development and optimization of RP-HPLC method for the estimation of s (-) amlodipine in tablet dosage form

Authors: J. Bagyalakshmi, Sincy Mary Philip, T. K. Ravi

Der Pharma Chemica

Volume 3 · Issue 4 · Pages 140–145

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

S(-) amlodipine is a potent calcium channel blocker used for the treatment of hypertension, congestive heart failure and angina pectoris. S(-) amlodipine avoids the adverse effect of amlodipine in racemic mixtures. The RP-HPLC method developed for the estimation of s (-) amlodipine in tablet dosage form was done by fixing the parameters as Phenomenex C8 ODS column (150 x 4.6 mm), 5 m particle size with mobile phase 20 mM sodium dihydrogen phosphate buffer: acetonitrile (65: 35% v/v) adjusted to pH 8 was used. Mobile phase flow rate was maintained at 1.2ml/min and detected at 239nm. The retention time was 4.20± 0.02 minutes

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharma Chemica.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “J. Bagyalakshmi”
  • BylineArticles whose byline prints “Sincy Mary Philip”
  • BylineArticles whose byline prints “T. K. Ravi”